Literature DB >> 11446874

Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease.

H G Tiselius1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11446874     DOI： 10.1046/j.1464-410x.2001.02308.x

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  9 in total

Review 1.  The use of risk indices: do they predict recurrence? Yes, they (at least some) do.

Authors:  Norbert Laube; Michael Pullmann
Journal:  Urol Res       Date:  2006-01-06

2.  Patients' attitudes on how to deal with the risk of future stone recurrences.

Authors:  Hans-Göran Tiselius
Journal:  Urol Res       Date:  2006-04-27

3.  Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers.

Authors:  F Vescini; A Buffa; G La Manna; A Ciavatti; E Rizzoli; A Bottura; S Stefoni; R Caudarella
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

4.  Bone and metabolic markers in women with recurrent calcium stones.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin; Salvador Arias-Santiago
Journal:  Korean J Urol       Date:  2013-03-15

Review 5.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

Review 6.  Randall's plaque and calcium oxalate stone formation: role for immunity and inflammation.

Authors:  Saeed R Khan; Benjamin K Canales; Paul R Dominguez-Gutierrez
Journal:  Nat Rev Nephrol       Date:  2021-01-29       Impact factor: 28.314

7.  Evaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy on kidney stone size.

Authors:  Hassan Niroomand; Amin Ziaee; Keivan Ziaee; Alaleh Gheissari
Journal:  Adv Biomed Res       Date:  2016-10-26

8.  Unusual clinical outcome of primary Hyperoxaluria type 1 in Tunisian patients carrying 33_34InsC mutation.

Authors:  Ibtihel Benhaj Mbarek; Saoussen Mdimeg; Amira Moussa; Dorsaf Zellama; Hayat Kaarout; Jaouida Abdelmoula; Abdellatif Achour; Saoussen Abroug; Asma Omezzine; Ali Bouslama
Journal:  BMC Nephrol       Date:  2017-06-15       Impact factor: 2.388

9.  Evaluating the effectiveness of adding magnesium chloride to conventional protocol of citrate alkali therapy in children with urolithiasis.

Authors:  Alaleh Gheissari; Amin Ziaee; Faezeh Farhang; Fatemeh Farhang; Zahra Talaei; Alireza Merrikhi; Taghi Ghafghazi; Mohsen Moslehi
Journal:  Int J Prev Med       Date:  2012-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.